RNA Advisors supports merger and acquisition (M&A) evaluations, planning and transactions in the life sciences and healthcare industries. Our expertise in market research, financial modeling, transaction structuring, and strategic analysis supports our clients with their decision-making processes, and our experience in complex transaction situations facilitates smoother and more effective stakeholder management. We are well-versed in understanding the financial ramifications of transaction structures on company performance, asset valuations, investment returns and other key metrics that affect our buy-side and sell-side clients.
